GlassScriptPhysician profile
Gaurav Kapoor
NPI 1245225192
$6,183.04
in general payments reported to CMS, 2019-2025
37 companies · $466 in 2025
The $466 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,529 · 2020: $61.47 · 2021: $290 · 2022: $466 · 2023: $458 · 2024: $1,913 · 2025: $466.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,795 · Consulting Fee: $1,000 · Travel and Lodging: $41.54.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,794.70 |
| Consulting Fee | $1,000.00 |
| Travel and Lodging | $41.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $1,457.69 | 2019 | |
| Cook Incorporated | $1,041.54 | 2024 | Gunther Tulip |
| Edwards Lifesciences Corporation | $778.16 | 2019-2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Boston Scientific Corporation | $344.09 | 2020-2025 | Watchman Flx, Watchman Access System |
| Novo Nordisk INC | $269.60 | 2024-2025 | Wegovy, Rybelsus, Ozempic |
| Boehringer Ingelheim Pharmaceuticals, INC. | $255.25 | 2019-2025 | Jardiance |
| Merck Sharp & Dohme LLC | $221.11 | 2022-2025 | Verquvo |
| Medtronic, INC. | $205.07 | 2021-2025 | Symplicity G3 |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $153.26 | 2023-2024 | Lifevest |
| Janssen Pharmaceuticals, INC | $134.74 | 2019-2024 | Xarelto |
| Abbott Laboratories | $133.51 | 2022-2023 | Perclose Prostyle |
| Lexicon Pharmaceuticals, INC. | $109.98 | 2023-2024 | Inpefa |
| Novartis Pharmaceuticals Corporation | $105.24 | 2024-2025 | |
| Philips North America LLC | $80.09 | 2022 | |
| Medtronic Vascular, INC. | $76.66 | 2019 |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gaurav Kapoor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.